Overview

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the effectiveness of 2 drugs, tacrolimus and sirolimus, in preventing graft versus host disease (GVHD) after treatment with chemotherapy followed by donor cord blood transplantation.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Dana-Farber Cancer Institute
Treatments:
Antilymphocyte Serum
Everolimus
Fludarabine
Melphalan
Sirolimus
Tacrolimus
Thymoglobulin